118 related articles for article (PubMed ID: 27871448)
1. Diagnostic and prognostic value of serum vitronectin levels in human glioma.
Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL
J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.
Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL
Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Gandhi P; Khare R; Garg N
J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.
Chen XY; Chen JY; Chen Y; Chen JF; Lin N; Ding CY; Kang DZ; Wang DL; Fang WH
Clin Neurol Neurosurg; 2021 Oct; 209():106912. PubMed ID: 34509141
[TBL] [Abstract][Full Text] [Related]
9. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
10. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
11. Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.
Liu ZY; Tang F; Wang J; Yang JZ; Chen X; Wang ZF; Li ZQ
BMC Cancer; 2024 Jun; 24(1):692. PubMed ID: 38844902
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
14. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas.
He ZQ; Duan H; Ke C; Zhang XH; Guo CC; Al-Nahari F; Zhang J; Chen ZH; Chen YS; Liu ZG; Wang J; Chen ZP; Jiang XB; Mou YG
Oncotarget; 2017 Jul; 8(30):49605-49614. PubMed ID: 28548947
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma.
Wang T; Niu X; Gao T; Zhao L; Li J; Gan Y; Liu Y; Mao Q
World Neurosurg; 2018 Apr; 112():e269-e277. PubMed ID: 29337167
[TBL] [Abstract][Full Text] [Related]
19. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
20. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
